Companies: 10,795·Total market cap: $144.5T
GeneDx Holdings Corp.

GeneDx Holdings Corp.

WGSNASDAQHealthcare● Active
$55.40
+$3.60(+6.95%)
Market Cap$1.6B
P/E Ratio
52W High$170.87
52W Low$32.21
Overview

GeneDx Holdings Corp. (WGS) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

wgs · stock forecast · 11 analysts (3M) · FMP · updated Jun 9, 2026

Analyst Rating & Consensus

Based on 11 Wall Street analysts in the past 3 months

SellBuy

Buy

11 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
10
Hold
1
Sell
0
Strong Sell
0
Total: 11 · Buy rate: 90.9%

12-Month Price Target

High

$150

Consensus

$96.43

+86.2% upside

Low

$70.00

Median: $85 · Last Close: $51.80

The GeneDx Holdings Corp. (WGS) analyst consensus is Buy, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month WGS price target is $96.43, representing +86.2% upside from the current price of $51.80.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $96 (86.2%)

Consensus Target

$96.43

86.2% upside

High Target

$150

189.6%

Low Target

$70

35.1%

Current Price

$51.80

as of today

Based on analyst price targets, the WGS stock price prediction for the next 12 months ranges from $70 to $150. The consensus WGS price forecast of $96.43 implies 86.2% upside from the current price of $51.80.

Short-Term Price Prediction

Bear

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-10$54.395.00%

1-day model range: $53.07–$55.71. Peak: $55.71 (+5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$78+50.0%
2028$99+91.2%
2029$114+120.2%
2030$124+138.5%
2031+149.4%
Confidence:MediumCapped at 50% annual limit

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

21%0%79%
3Buy
0Neutral
11Sell
RSI (14)70.8Overbought
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · WGS · Jun 9, 2026

Simple Moving Average (SMA)
MA 5$53.29SELL
MA 10$51.82SELL
MA 20$47.00BUY
MA 50$55.65SELL
MA 100$71.26SELL
MA 200$102.14SELL
Current $WGS · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$52.56SELL
EMA 10$51.44BUY
EMA 20$50.73BUY
EMA 50$57.25SELL
EMA 100$71.11SELL
EMA 200$83.89SELL
Current $WGS · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Canaccord Genuity2026-05-05
Maintains
BuyBuy
Wells Fargo2026-05-05
Maintains
OverweightOverweight
Guggenheim2026-05-05
Maintains
BuyBuy
BTIG2026-05-05
Maintains
BuyBuy
Canaccord Genuity2026-04-20
Maintains
BuyBuy
Guggenheim2026-03-30
Maintains
BuyBuy
BTIG2026-02-24
Maintains
BuyBuy
Piper Sandler2026-02-24
Maintains
OverweightOverweight
Wells Fargo2026-02-09
Upgrade ↑
Equal WeightOverweight
Canaccord Genuity2025-12-22
Maintains
BuyBuy

Wall Street analysts have recently issued updated ratings on GeneDx Holdings Corp. (WGS) stock. Of the recent 50 rating actions, 2 were upgrades and 2 were downgrades. 11 analysts currently cover WGS.

Analyst Recommendation Trends

Buy ratings04↑ +4
Hold ratings101
Sell ratings00

WGS analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 4 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$478M

↓ 36.6% YoY

Revenue Next Year

$595M

↑ 24.4% YoY

EPS This Year

$-0.07

EPS Next Year

$1.23

↓ 1823.7% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast WGS EPS of $-0.07 for the current fiscal year, based on estimates from 4 analysts. The WGS revenue forecast is $478M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The WGS stock forecast is supported by two independent data sources: analyst consensus ratings from 11 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus WGS price target is $96.43 (+86.2% upside), with an analyst consensus of Buy.

The WGS short-term stock prediction for tomorrow is $54.39 (+5.00%). The WGS stock price prediction for 2027 estimates an average of $78. The WGS stock prediction for 2030 projects a range of $98–$149.

GeneDx Holdings Corp. trades on NASDAQ under the ticker WGS. The WGS stock outlook for 2027 is broadly positive, supported by a Buy consensus among 91% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

WGS forecast · 8 questions

According to 11 Wall Street analysts, the average 12-month WGS price target is $96.43, with a high forecast of $150.00 and a low of $70.00. The median price target is shown in the chart above when available. This implies +86.2% potential upside from the current price of $51.80.

WGS price targetWhat is WGS price targetWGS analyst price targetWGS 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.